What is Proximity?
Proximity operates at the nexus of healthcare administration and financial technology. The company provides an intelligent automation platform that simplifies the management of the federal 340B drug pricing program for qualified healthcare providers. By centralizing disparate data streams from electronic health records, third-party administrators, and pharmaceutical wholesalers, Proximity enables providers to maximize revenue capture while simultaneously mitigating compliance risks and manufacturer-related threats. Under the leadership of CEO and Founder Scott Johnsen, the firm addresses a significant pain point in the healthcare sector: the resource-intensive nature of maintaining 340B program integrity. Its technology serves as a force multiplier for hospital systems, transforming complex regulatory requirements into a streamlined, revenue-generating asset.
How much funding has Proximity raised?
Proximity has raised a total of $3M across 1 funding round:
Angel/Seed
$3M
Angel/Seed (2025): $3M with participation from Commonwealventures and LRVHealth
Key Investors in Proximity
Commonwealventures
Commonweal Ventures is an investment firm that supports early-stage companies in sectors including health, energy, and cybersecurity by leveraging government partnerships to accelerate growth.
LRVHealth
LRVHealth is a Boston-based venture capital firm focused on identifying, investing in, and building disruptive digital health, medical device, and diagnostic companies.
What's next for Proximity?
With this major enterprise-level funding, Proximity is poised to transition from its initial development phase into a period of aggressive market scaling. The strategic roadmap likely includes enhancing the platform's predictive analytics capabilities to further safeguard against evolving compliance concerns and manufacturer audits. Furthermore, the company is expected to invest in talent acquisition and business development to broaden its reach among large-scale healthcare networks. As the regulatory environment surrounding 340B programs remains dynamic, Proximity's ability to provide a centralized, intelligent source of truth will be instrumental in maintaining its competitive advantage. The firm is now positioned to solidify its role as an essential partner for health systems seeking to optimize financial performance without compromising operational efficiency.
See full Proximity company page
